ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,446Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 1111

$623K Total Retail Price of All Prescriptions

Rank: 138 out of 1111

542 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 542 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 12,077 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 862 748 1 2
AMLODIPINE BESYLATE 711 692 2 7
CARVEDILOL 643 581 3 21
HYDROCODONE-ACETAMINOPHEN 606 474 S3 4 1
SIMVASTATIN 527 436 5 5
ATORVASTATIN CALCIUM 469 402 6 15
LEVOTHYROXINE SODIUM 468 381 7 3
METFORMIN HCL 404 363 8 8
OMEPRAZOLE 371 302 9 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 349 327 10 23
GABAPENTIN 294 221 11 10
GLIMEPIRIDE 287 229 12 61
HYDROCHLOROTHIAZIDE 225 194 13 11
CITALOPRAM HBR 208 186 14 14
PRAVASTATIN SODIUM 195 171 15 17
FLUOXETINE HCL 188 137 16 44
FENOFIBRATE 180 130 17 95
LOSARTAN POTASSIUM 176 164 18 34
FLUTICASONE PROPIONATE 173 134 19 27
TRAMADOL HCL 171 155 20 13
WARFARIN SODIUM 168 147 21 19
LOSARTAN-HYDROCHLOROTHIAZIDE 156 141 22 72
METOPROLOL TARTRATE 148 133 23 12
ATENOLOL 138 106 24 22
NEXIUM 133 84 25 26
FUROSEMIDE 130 120 26 6
POTASSIUM CHLORIDE 130 104 26 9
VENLAFAXINE HCL ER 124 84 28 105
TAMSULOSIN HCL 123 110 29 28
ALLOPURINOL 120 107 30 36
ESTRADIOL 120 101 R 30 102
PANTOPRAZOLE SODIUM 117 116 32 50
ADVAIR DISKUS 115 78 33 43
SPIRIVA 113 96 34 53
SERTRALINE HCL 109 105 35 24
PROAIR HFA 87 51 36 38
DIGOXIN 86 79 37 47
LANTUS 81 63 38 46
OXYCODONE-ACETAMINOPHEN 79 35 S2 39 147
METOPROLOL SUCCINATE 78 78 40 20
ALENDRONATE SODIUM 75 73 41 35
FINASTERIDE 73 61 42 115
RANITIDINE HCL 71 51 43 29
ZOLPIDEM TARTRATE 71 59 43 16
BUSPIRONE HCL 70 60 45 96
CYCLOBENZAPRINE HCL 70 39 R 45 37
CLOPIDOGREL 70 62 45 30
LYRICA 65 56 48 62
CELEBREX 64 38 49 81
INSULIN SYRINGE 63 61 50 167
PRAMIPEXOLE DIHYDROCHLORIDE 63 41 50 186
CARBIDOPA-LEVODOPA 61 49 52 101
TRAZODONE HCL 61 51 52 32
LOVASTATIN 60 59 54 41
AMLODIPINE BESYLATE-BENAZEPRIL 60 57 54 67
LIPITOR 58 53 56 116
FENTANYL 56 55 S2 57 65
PLAVIX 53 41 58 49
CYMBALTA 53 25 58 40
LANTUS SOLOSTAR 53 45 58 135
ROPINIROLE HCL 53 49 58 68
TIZANIDINE HCL 53 30 58 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.